Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein

作者: Joseph De Angelo , Robert G. Kilbourn , Joseph Bonaventura

DOI:

关键词:

摘要: The invention is directed to a method for the prophylaxis or treatment of an animal deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced biological response modifier. Examples modifiers include but are not limited cytokine and endotoxin. also septic shock.

参考文章(69)
Joseph Bonaventura, Celia Bonaventura, David Bickar, Method for catalyzing oxidation/reduction reactions of simple molecules ,(1984)
D Bickar, C Bonaventura, J Bonaventura, Carbon monoxide-driven reduction of ferric heme and heme proteins. Journal of Biological Chemistry. ,vol. 259, pp. 10777- 10783 ,(1984) , 10.1016/S0021-9258(18)90579-X
A. J. Brady, P. A. Poole-Wilson, S. E. Harding, J. B. Warren, Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 263, ,(1992) , 10.1152/AJPHEART.1992.263.6.H1963
G Lopez-Berestein, J Klostergaard, R G Kilbourn, Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. Journal of Immunology. ,vol. 133, pp. 2577- 2581 ,(1984)
R M Palmer, S Moncada, E A Higgs, NITRIC OXIDE: PHYSIOLOGY, PATHOPHYSIOLOGY, AND PHARMACOLOGY Pharmacological Reviews. ,vol. 43, pp. 109- 142 ,(1991)